(Q28140514)

English

Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use

scientific article (publication date: November 2000)

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

breast carcinoma

1 reference

based on heuristic

inferred from title

author name string

A Bánkfalvi

1

0 references

R Simon

2

0 references

B Brandt

3

0 references

H Bürger

4

0 references

I Vollmer

5

0 references

B Dockhorn-Dworniczak

6

0 references

R J Lellé

7

0 references

W Boecker

8

0 references

language of work or name

0 references

publication date

November 2000

0 references

0 references

37

0 references

5

0 references

411-9

0 references

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

The neu oncogene encodes an epidermal growth factor receptor-related protein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

Functional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overexpressing invasive human breast tumours

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2000.00984.X

21 January 2018

Identifiers

10.1046/J.1365-2559.2000.00984.X

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28140514&oldid=2164749843"